ArticleCancer research communications2023

A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma.

Daniel Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.